Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julie Hambleton currently holds 29,888 shares of IGM Biosciences, Inc. (IGMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Hambleton has been a net seller of IGMS stock. They have purchased $209.6K and sold $1.6M worth of shares.
Julie Hambleton's most recent insider trade was on Jun 26, 2026, when they sold 29,888 shares at $0.00 per share.
Julie Hambleton serves as Executive at IGM Biosciences, Inc. (IGMS). They have executed 36 insider transactions totaling $1.8M over their tenure at the company.
Julie Hambleton holds the position of Executive at IGM Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Julie Hambleton has shown a selling trading pattern, with $209.6K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Julie Hambleton was on Nov 11, 2015, when they sold $412.0K worth of FPRX shares. This transaction involved 12,000 shares at $34.33 per share.
Julie Hambleton currently owns 29,888 shares of IGM Biosciences, Inc. (IGMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julie Hambleton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julie Hambleton has 36 Form 4 filings on record as an insider at IGM Biosciences, Inc..
Set alerts for Julie Hambleton and 40,000+ other insiders.